Advanced Screening Approaches in Drug Discovery

Online Symposium

23 October 2024 | Online, BST (UTC+1)

Bringing together key opinion leaders from across the globe for focused discussions on using the latest screening technologies in drug discovery

Key Topics Covered

  • Fragment screening platforms
  • CRISPR screening
  • Phenotypic screening
  • Target-based
  • Virtual & structure-based approaches
  • Advanced cell screening

Benefits of Attending

  • Meet with global key innovators in a focused symposium to hear the latest case studies in utilizing advanced screening approaches for drug target identification & validation. This programme takes a deep dive into best practice screening approaches & technological advancements, bringing together thought leaders from across the globe for focused discussions & networking
  • Stay at the forefront of innovation by hearing about the latest advancements, cutting-edge techniques, and emerging trends in fragment-based and CRISPR screening approaches used to identify and validate novel drug targets
  • Discuss the latest developments in improved cell screening platforms to advance drug discovery efforts and virtual & structure-based approaches to screening
  • Followed by the release of the ‘Harnessing Advanced Screening Approaches for Drug Target Identification & Validation’ report detailing key insights, methodologies, and emerging trends discussed during the event for leveraging drug discovery screening approaches effectively 



Latest Resources

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.

Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients

The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.

ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers

The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.

Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study

Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.

New Zika-Specific Synthetic Biomarker Can Differentiate From Dengue Virus

A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.

Meet Our Expert Speakers

Advanced Screening Approaches in Drug Discovery again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Confirmed speakers include:

Julien Orts
Assoc. Prof. Dr.,
Uni. Vienna
Leire Escudero-Ibarz
Associate Director,
AstraZeneca
Linda Kitching
Associate Director,
AstraZeneca
Nazia Parvez
Investigator,
GSK

Register Your Interest

Submit your details and a member of our team will be in touch